[1]
Gurevičienė, G. 2022. FIRST LINE TREATMENT OF UNRESECTABLE MALIGNANT PLEURAL MESOTHELIOMA WITH NIVOLUMAB PLUS IPILIMUMAB. Pulmonology and allergology. 6, 2 (Oct. 2022), 223-231. DOI:https://doi.org/10.37499/PIA.1026.